25E-NBOMe

25E-NBOMe
Clinical data
Other names	2C-E-NBOMe; NBOMe-2C-E; N-(2-Methoxybenzyl)-4-ethyl-2,5-dimethoxyphenethylamine
Drug class	Serotonin 5-HT2 receptor agonist; Serotonergic psychedelic; Hallucinogen
Legal status
Legal status	BR: Class F2 (Prohibited psychotropics); DE: NpSG (Industrial and scientific use only); UK: Class A;
Identifiers
	IUPAC name 2-(4-ethyl-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine;
CAS Number	1354632-14-6;
PubChem CID	118796522;
ChemSpider	52085495 ;
UNII	02HX6G35T3;
CompTox Dashboard (EPA)	DTXSID901014188 ;
Chemical and physical data
Formula	C20H27NO3
Molar mass	329.440 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES COC(C=CC=C1)=C1CNCCC2=C(OC)C=C(CC)C(OC)=C2;
	InChI InChI=1S/C20H27NO3/c1-5-15-12-20(24-4)16(13-19(15)23-3)10-11-21-14-17-8-6-7-9-18(17)22-2/h6-9,12-13,21H,5,10-11,14H2,1-4H3 ; Key:PXDVGFGXPVCNAB-UHFFFAOYSA-N ;

25E-NBOMe, also known as 2C-E-NBOMe or NBOMe-2C-E, is a derivative of the phenethylamine 2C-E. It acts in a similar manner to related compounds such as 25I-NBOMe, which are potent agonists at the 5-HT_2A receptor. 25E-NBOMe has been sold as a drug and produces similar effects in humans to related compounds such as 25I-NBOMe and 25C-NBOMe.